Experience with 23-valent pneumococcal polysaccharide vaccine in patients with ankylosing spondylitis and psoriatic arthritis | Baranova | Medical alphabet

Medical alphabet
Medicinskij alfavit

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

eng | рус

Preview

Medical alphabet

Advanced search

Archives

Download this PDF file

For citations:

Baranova M.M., Muravyeva N.V., Belov B.S., Verizhnikova Zh.G. Experience with 23-valent pneumococcal polysaccharide vaccine in patients with ankylosing spondylitis and psoriatic arthritis. Medical alphabet. 2023;(31):15-20. (In Russ.) https://doi.org/10.33667/2078-5631-2023-31-15-20

Views PDF (Rus): 4

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Petrikov Sergey S.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. M. Baranova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Marina M. Baranova - Researcher at Laboratory for Studying Comorbid Infections and Vaccination Prevention.

Moscow

N. V. Muravyeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Natalia V. Muravyeva - PhD Med., senior researcher at Laboratory for Studying Comorbid Infections and Vaccination Prevention.

Moscow

B. S. Belov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Boris S. Belov - DM Sci (habil.), head of Laboratory for Studying Comorbid Infections and Vaccination Prevention.

Moscow

Zh. G. Verizhnikova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Zhanna G. Verizhnikova - researcher at Laboratory of Immunology and Molecular Biology of Rheumatic Diseases.

Moscow

Notifications